Status and phase
Conditions
Treatments
About
Single centre, dose finding trial to establish the minimum effective dose of dobutamine required to treat hemodynamic insufficiency, defined as low superior vena cava (SVC) flow, in infants below 33 weeks' gestation during transitional circulation (first 72 hours from birth).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
30 participants in 5 patient groups
Loading...
Central trial contact
Adelina Pellicer, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal